DIOSYNTH Trademark

Trademark Overview


On Friday, October 2, 2015, a trademark application was filed for DIOSYNTH with the United States Patent and Trademark Office. The USPTO has given the DIOSYNTH trademark a serial number of 79199948. The federal status of this trademark filing is PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED as of Thursday, October 31, 2024. This trademark is owned by FUJIFILM Corporation. The DIOSYNTH trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Services of biotechnical, chemical and pharmacological laboratories, namely, scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations; scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations, and scientific consultation related thereto; scientific research, namely, carrying out early evaluations in the field of new medicines; development of pharmaceutical preparations, medicines and medicaments; technological services, namely, technological consultation and research in the field of new product development in the pharmaceutical and health care industries; scientific analysis and research, namely, evaluation of pharmaceutical products; research and development in the pharmaceutical field; scientific research and development with regard to medicines; product dev...

Custom manufacture of pharmaceuticals

[ Medicines and pharmaceutical products, including medicines and pharmaceutical products for veterinary use, namely, medicines and pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital disorders and, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory disease, respiratory and infectious diseases, immunological, bacterial, viral and fungal disorders, mental illness, depression, psychosis, bone and mineral diseases, infertility, menopausal complaints, hormone deficiencies, and sleep disorders; pharmaceutical preparations, namely, preparations to lower cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations, contraceptives, muscle relaxants, mu...

[ Chemical preparations and substances for manufacturing of pharmaceutical products, namely, chemical preparations and substances for manufacturing pharmaceutical products for veterinary applications; chemical additives for manufacturing medicines; chemicals for manufacturing cosmetics, skin cleansers and medicines; chemical preservatives for pharmaceutical preparations; biochemicals, namely, polypeptides, recombinant proteins, organic peptide substrates and monoclonal antibodies for producing products for genetic pharmacology ]
diosynth

General Information


Serial Number79199948
Word MarkDIOSYNTH
Filing DateFriday, October 2, 2015
Status708 - PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateThursday, October 31, 2024
Registration Number5273482
Registration DateTuesday, August 29, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2017

Trademark Statements


Goods and ServicesServices of biotechnical, chemical and pharmacological laboratories, namely, scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations; scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations, and scientific consultation related thereto; scientific research, namely, carrying out early evaluations in the field of new medicines; development of pharmaceutical preparations, medicines and medicaments; technological services, namely, technological consultation and research in the field of new product development in the pharmaceutical and health care industries; scientific analysis and research, namely, evaluation of pharmaceutical products; research and development in the pharmaceutical field; scientific research and development with regard to medicines; product development, namely, preparation of pharmaceutical test products; advisory services relating to scientific research, development and analyses of medicines; development of new technologies in the biotechnology sector; providing information with regard to scientific research in the field of biochemistry and biotechnology; scientific research, including in the medical sector
Goods and ServicesCustom manufacture of pharmaceuticals
Goods and Services[ Medicines and pharmaceutical products, including medicines and pharmaceutical products for veterinary use, namely, medicines and pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital disorders and, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory disease, respiratory and infectious diseases, immunological, bacterial, viral and fungal disorders, mental illness, depression, psychosis, bone and mineral diseases, infertility, menopausal complaints, hormone deficiencies, and sleep disorders; pharmaceutical preparations, namely, preparations to lower cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations, contraceptives, muscle relaxants, muscle relaxant antagonists; biotechnological preparations for medical use, namely use in gene therapy; biochemicals, namely, biochemical preparations for medical use, namely use in gene therapy; genetic material, namely, genetically engineered tissue, for transplant purposes for genetic cell therapy ]
Goods and Services[ Chemical preparations and substances for manufacturing of pharmaceutical products, namely, chemical preparations and substances for manufacturing pharmaceutical products for veterinary applications; chemical additives for manufacturing medicines; chemicals for manufacturing cosmetics, skin cleansers and medicines; chemical preservatives for pharmaceutical preparations; biochemicals, namely, polypeptides, recombinant proteins, organic peptide substrates and monoclonal antibodies for producing products for genetic pharmacology ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeG - NOT AVAILABLE
Class Status DateThursday, October 31, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateThursday, October 31, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2017
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFUJIFILM Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 106-8620
JP

Party NameFUJIFILM Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 106-8620
JP

Party NameFUJIFILM Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 106-8620
JP

Trademark Events


Event DateEvent Description
Thursday, January 5, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 13, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, January 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 17, 2017ASSIGNED TO EXAMINER
Wednesday, January 18, 2017NON-FINAL ACTION WRITTEN
Thursday, January 19, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, January 21, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, January 24, 2017REFUSAL PROCESSED BY MPU
Tuesday, January 24, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 18, 2017REFUSAL PROCESSED BY IB
Tuesday, April 18, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 18, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 24, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 24, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 2, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 24, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 13, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 13, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 29, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, November 29, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, December 13, 2017FINAL DISPOSITION PROCESSED
Wednesday, December 13, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, January 6, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 29, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, January 13, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, August 22, 2023TEAS SECTION 71 & 15 RECEIVED
Monday, April 22, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 16, 2024POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Saturday, October 12, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, October 31, 2024REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, October 31, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Monday, June 30, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, October 9, 2025INTERNATIONAL REGISTRATION RENEWED
Monday, December 8, 2025GENERIC MADRID TRANSACTION CREATED
Monday, December 8, 2025GENERIC MADRID TRANSACTION SENT TO IB